Health Sciences
Where do toxins from tobacco attack DNA?
Research
ETH Zurich
It is known that toxins in tobacco smoke can change our DNA – but where exactly in the genome they do this has been a mystery. A new approach developed by researchers at ETH Zurich now brings light into the darkness. In the future, this could make it easier than ever to determine the safety of many chemical substances.
Using light to switch drugs on and off
Research
PSI
Scientists at the Paul Scherrer Institute PSI have used the Swiss X-ray free-electron laser SwissFEL and the Swiss Light Source SLS to make a film that could give a decisive boost to developing a new type of drug. They made the advance in the field of so-called photopharmacology, a discipline that develops active substances which can be specifically activated or deactivated with the help of light. The study is being published today in the journal Nature Communications.
Oral bacteria may increase heart disease risk
Research
EPFL
Researchers at EPFL have found that infection with a common bacterium that is linked to periodontal disease, oral cancers, and bad breath may cause a small increase in the risk of cardiovascular disease.
EPFL startup develops system for producing blood platelets on demand
TechTransfer
EPFL
Blood platelets can be stored for only up to a week, and hospitals often run short of this life-saving resource. To help overcome this problem, an EPFL startup called HemostOD has developed technology that can produce blood platelets in large volumes and on demand.
Hope for patients with a severe rare disease
Research
ETH Zurich
New research offers potential benefits for those affected by the hereditary metabolic disease methylmalonic aciduria. By combining the results of multiple molecular analyses, scientists can better diagnose this rare and severe disease. In the future, an improved understanding of the disease might also improve treatment options.
More Precise Treatment
Research
ETH Zurich
The LOOP Zurich research center combines expertise from ETH Zurich, the University of Zurich and the four university hospitals in Zurich with the aim of developing more personalized therapies. Two new projects supported by The LOOP Zurich target urinary tract infections and obesity respectively.
Page 11 of 24